Weinberg Uri's Form 4/A amendment
AmendedNovoCure Ltd (NVCR) · filed Mar 3, 2025
- Accession no.
- 0001562180-25-001917
- Filed
- Mar 3, 2025
- Trade date
- Feb 28, 2025
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Mar 3, 2025
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $86.9K. It was filed 3 days after the trade.
This amendment replaces 0001562180-25-001837 (filed Mar 3, 2025).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Weinberg UriCIK 0001811030 | Officer (Chief Innovation Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 28, 2025 | Ordinary Shares | SSaleDisposed | −4,326 | $18.78 | −$81,242.28 | 166,822 | Direct | |
| Feb 28, 2025 | Ordinary Shares | SSaleDisposed | −311 | $18.31 | −$5,694.41 | 166,511 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.